Diabetic mice receiving JAK1 and JAK2 inhibitors showed that this treatment downregulates the expression of STAT3-dependent genes, such as Notch1, TGF-β, and CCR2, which are the driving factors of DKD (Zhang et al., 2017). The gene discussed is JAK1; the disease is diabetic kidney disease.